Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis ...

Eupraxia Pharmaceuticals reported new trial data showing EP-104GI improved esophagus tissue health and maintained remission ...

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete improvement in tissue health1- At lower doses, patients maintained the improvem ...

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete ...

Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue guidance to $174.5-$175.5 million.

SPRINGFIELD, Mo. (KY3) - Bowen Hohensee crosses the finish line with a laugh, whether he wins or loses the game. The 2-year-old has already survived a much more challenging journey than most people ...

Navigating everyday life with eosinophilic esophagitis (EoE) can come with challenges, and those can be magnified when you’re traveling. Figuring out which foods are safe to eat, being far from your ...

Eosinophilic esophagitis (EoE) is no longer a rarity in European clinics. Diagnosed increasingly over the past three decades, EoE is commonly managed with pharmacotherapy, elimination diets, and, when ...

“In EoE, PPIs are used for anti-inflammatory properties rather than acid suppression,” says Alex Koral, MD, a gastroenterologist and an associate professor of pediatric gastroenterology at Yale School ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Phathom Pharmaceuticals ( (PHAT)) has ...

Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. VICTORIA, ...

Patients with eosinophilic esophagitis (EoE) often describe the condition as painful, disruptive and frightening. The rare chronic disease causes inflammation of the esophagus, leading to abdominal ...